n.a. (ELN)

0.00
NYSE
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NYSE
Div & Yield N.A. (N.A)
Elan Announces Filing Of Annual Report For Year Ended December 31, 2010

Elan Announces Filing Of Annual Report For Year Ended December 31, 2010

Elan Corporation, plc (NYSE:ELN) today announced the publication and filing of its Annual Report for the fiscal year ended December 31, 2010.

Elan Announces First European Commission Approval Of Injectable Treatment Using Elan’s NanoCrystal® Technology

Elan Announces First European Commission Approval Of Injectable Treatment Using Elan’s NanoCrystal® Technology

Elan Drug Technologies (EDT), the drug delivery unit of Elan Corporation, plc (NYSE: ELN), today announced that the first injectable product using EDT’s NanoCrystal ® technology has been approved by the...

Elan To Present At The Barclays Capital 2011 Global Healthcare Conference

Elan To Present At The Barclays Capital 2011 Global Healthcare Conference

Elan Corporation, plc (NYSE:ELN) announced today that it will present at the Barclays Capital 2011 Global Healthcare Conference on Tuesday March 15, 2011 at 11.

Abraham, Fruchter & Twersky, LLP Announces Filing Of Class Action Lawsuit Against Elan Corporation, PLC

Abraham, Fruchter & Twersky, LLP Announces Filing Of Class Action Lawsuit Against Elan Corporation, PLC

Abraham, Fruchter & Twersky, LLP announces that a class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of a class (the “Class”) of investors...

SFMS Files Class Action Lawsuit Against Elan Corporation, PLC

SFMS Files Class Action Lawsuit Against Elan Corporation, PLC

Shepherd, Finkelman, Miller & Shah, LLP ( http://www.sfmslaw.

Elan And Celgene Enter Into Settlement And License Agreement Related To ABRAXANE®

Elan And Celgene Enter Into Settlement And License Agreement Related To ABRAXANE®

Elan Corporation plc (NYSE: ELN) and Celgene Corporation (Nasdaq:CELG), today announced that Elan subsidiary Elan PharmaInternational Limited has entered into a settlement and license agreement with Celgene Corporation...

Elan Announces Filing Of Annual Report On Form 20-F For Year Ended December 31, 2010

Elan Announces Filing Of Annual Report On Form 20-F For Year Ended December 31, 2010

Elan Corporation, plc (NYSE: ELN) today announced the filing of its Annual Report on Form 20-F for the fiscal year ended December 31, 2010.

Elan To Present At The Cowen And Company 31st Annual Health Care Conference

Elan To Present At The Cowen And Company 31st Annual Health Care Conference

Elan Corporation, plc (NYSE: ELN) announced today that it will present at the Cowen and Company 31 st Annual Health Care Conference on Wednesday March 9, 2011 at 10:15 a.

Elan And PPD Announce Global Business Relationship In Drug Development

Elan And PPD Announce Global Business Relationship In Drug Development

Elan, plc (NYSE: ELN) and PPD, Inc. (Nasdaq: PPDI) today announced they have formed a global business collaboration focused on the advancement, progression and execution of Elan’s development portfolio.

Elan And Boehringer Ingelheim Announce Development And Manufacturing Agreement For Elan’s Antibody-Based Therapeutics Pipeline

Elan And Boehringer Ingelheim Announce Development And Manufacturing Agreement For Elan’s Antibody-Based Therapeutics Pipeline

Elan plc (NYSE: ELN) and Boehringer Ingelheim today announced that they have entered into a global technical development and manufacturing agreement for antibody-based therapeutics.

Elan Reports Fourth Quarter And Full-Year 2010 Financial Results

Elan Reports Fourth Quarter And Full-Year 2010 Financial Results

Elan Corporation, plc today reported its fourth quarter and full-year 2010 financial results and provided financial guidance for 2011.

Elan Draws Call-Buyers Ahead of Earnings

Elan Draws Call-Buyers Ahead of Earnings

Elan received upside option activity ahead of the drugmaker's earnings report Tuesday morning.

Elan Announces Webcast Of Fourth Quarter And Full Year 2010 Financial Results

Elan Announces Webcast Of Fourth Quarter And Full Year 2010 Financial Results

Elan Corporation, plc (NYSE: ELN) announced today that it will host a conference call on Tuesday February 8, 2011 at 8:30 a.

Biogen Idec And Elan Submit Applications To Update TYSABRI Labeling That May Help Stratify Risk Of PML With Anti-JC Virus Antibody Status

Biogen Idec And Elan Submit Applications To Update TYSABRI Labeling That May Help Stratify Risk Of PML With Anti-JC Virus Antibody Status

Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) announced that the companies have submitted a supplemental Biologics License Application (sBLA) to the U.

Amanda Freitag Of Chopped And Iron Chef America Teams Up With Multiple Sclerosis Nutritionist To Create Nutrition Resource For People With MS

Amanda Freitag Of Chopped And Iron Chef America Teams Up With Multiple Sclerosis Nutritionist To Create Nutrition Resource For People With MS

Amanda Freitag, celebrity chef and recurring judge on the Food Network’s “Chopped,” and Julie Barto, a registered dietitian specializing in multiple sclerosis (MS), have teamed up to create a nutrition...

Elan Finalizes Previously Disclosed Settlement Related To Past Zonegran Sales And Marketing Activities

Elan Finalizes Previously Disclosed Settlement Related To Past Zonegran Sales And Marketing Activities

Elan Corporation, plc ("Elan") (NYSE: ELN) announced today that it has finalized the agreement-in-principle with the United States Attorney's Office for the District of Massachusetts to resolve all aspects of the U.

Worst Biotech CEO of 2010 Is...

Worst Biotech CEO of 2010 Is...

TheStreet's readers picked Amylin's Dan Bradbury as the worst biotech CEO of the year.

Elan Names Robert A. Ingram Chairman-Designate

Elan Names Robert A. Ingram Chairman-Designate

Elan Corporation, plc ("Elan") (NYSE: ELN) today announced that the Company’s Board of Directors has appointed Robert A.

Biotech Stock Mailbag: Amarin

Biotech Stock Mailbag: Amarin

Biotech columnist Adam Feuerstein answers readers' questions and concerns about healthcare and drug-related stocks.

Vote for the Worst Biotech CEO of 2010

Vote for the Worst Biotech CEO of 2010

Readers of TheStreet's biotech coverage will vote on which chief executive deserves this most ignominious award.

Elan To Present At Lazard Capital Markets 7th Annual Healthcare Conference

Elan To Present At Lazard Capital Markets 7th Annual Healthcare Conference

Elan Corporation, plc (NYSE: ELN) today announced that it will present at the Lazard Capital Markets 7 th Annual Healthcare Conference, on Tuesday, November 16, 2010 at 9:55 a.

Two Directors Step Down From Elan Board In Accordance With Previously Announced Intention

Elan Corporation, plc (“Elan”) (NYSE: ELN) said today that two of its directors, Jack Schuler and Vaughn Bryson, resigned from the Board effective October 29, 2010, in accordance with their previously ...

Elan Reports Third Quarter 2010 Financial Results

Elan Reports Third Quarter 2010 Financial Results

Elan Corporation, plc today reported its third quarter and first nine months 2010 financial results.

Data Further Supporting Anti-JC Virus Antibody Assay Presented At The 26th Congress Of The European Committee For Treatment And Research In Multiple Sclerosis

Data Further Supporting Anti-JC Virus Antibody Assay Presented At The 26th Congress Of The European Committee For Treatment And Research In Multiple Sclerosis

Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) today announced data further supporting the potential clinical utility of an investigational assay that detects anti-JC virus (JCV) antibodies...

Elan Announces Webcast Of Third Quarter 2010 Financial Results

Elan Corporation, plc (NYSE: ELN) announced today that it will host a conference call on Wednesday, October 27, 2010 at 8:30 a.

Elan Announces Official Launch Of Manufacturing Services Business At CPhI World Meeting On October 5 In Paris And The Appointment Of Philip Pratten As VP Manufacturing Services Operations.

Elan Drug Technologies, a business unit of Elan Corporation, plc (NYSE: ELN) announces plans to officially launch its Manufacturing Services business at the CPhI world event in Paris on October 5.

Elan Corporation Plc Announces Expiration Of Asset Sale Offer To Purchase Up To $186,000,000 Of 8 7/8% Senior Fixed Rate Notes Due 2013 And Floating Rate Notes Due 2013

Elan Corporation, plc (“Elan”) (NYSE:ELN) today announced the expiration and final results of the previously announced asset sale offer to purchase up to $186,000,000 aggregate principal amount of the 8 7/8% ...

Elan To Present At The Jefferies 2010 Global SpecPharma And European Healthcare Conference

Elan Corporation, plc (NYSE: ELN) today announced that it will present at the Jefferies 2010 Global SpecPharma and European Healthcare Conference on Wednesday, October 6, 2010, at 2:00 p.

Elan Board Unanimously Accepts McKenna Long Report

Elan Board Unanimously Accepts McKenna Long Report

Elan Corporation, plc (“Elan”) (NYSE: ELN) announced that at yesterday’s meeting of the Elan Board of Directors, the Board unanimously accepted a report prepared by the United States law firm of McKenna Long...

The MS Active Wellness Fitness Program Can Be Modified As Necessary So Almost All People With MS Can Participate In The Workouts, Regardless Of Current Ability Or Fitness Level. (Photo: Business Wire)

Biogen Idec and Elan Corporation, plc today announced the launch of MS Active Wellness, a new resource available through MS ActiveSource, which provides tools to help people with multiple sclerosis (MS) achieve...